The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA Trial Academic Article uri icon

Overview

MeSH Major

  • Brain Ischemia
  • Fibrinolytic Agents
  • Stroke
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator

abstract

  • The THRIVE score provides accurate prediction of long-term neurologic outcomes in patients with acute ischemic stroke regardless of treatment modality. Both the THRIVE score and tPA administration predict outcome, but the THRIVE score does not influence the impact of tPA on outcome, and tPA administration does not influence the impact of THRIVE score on outcome.

publication date

  • October 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jstrokecerebrovasdis.2012.08.017

PubMed ID

  • 23122722

Additional Document Info

start page

  • 1111

end page

  • 6

volume

  • 22

number

  • 7